Unknown

Dataset Information

0

Potent inhibition of DOT1L as treatment of MLL-fusion leukemia.


ABSTRACT: Rearrangements of the MLL gene define a genetically distinct subset of acute leukemias with poor prognosis. Current treatment options are of limited effectiveness; thus, there is a pressing need for new therapies for this disease. Genetic and small molecule inhibitor studies have demonstrated that the histone methyltransferase DOT1L is required for the development and maintenance of MLL-rearranged leukemia in model systems. Here we describe the characterization of EPZ-5676, a potent and selective aminonucleoside inhibitor of DOT1L histone methyltransferase activity. The compound has an inhibition constant value of 80 pM, and demonstrates 37?000-fold selectivity over all other methyltransferases tested. In cellular studies, EPZ-5676 inhibited H3K79 methylation and MLL-fusion target gene expression and demonstrated potent cell killing that was selective for acute leukemia lines bearing MLL translocations. Continuous IV infusion of EPZ-5676 in a rat xenograft model of MLL-rearranged leukemia caused complete tumor regressions that were sustained well beyond the compound infusion period with no significant weight loss or signs of toxicity. EPZ-5676 is therefore a potential treatment of MLL-rearranged leukemia and is under clinical investigation.

SUBMITTER: Daigle SR 

PROVIDER: S-EPMC3739029 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


Rearrangements of the MLL gene define a genetically distinct subset of acute leukemias with poor prognosis. Current treatment options are of limited effectiveness; thus, there is a pressing need for new therapies for this disease. Genetic and small molecule inhibitor studies have demonstrated that the histone methyltransferase DOT1L is required for the development and maintenance of MLL-rearranged leukemia in model systems. Here we describe the characterization of EPZ-5676, a potent and selectiv  ...[more]

Similar Datasets

| S-EPMC3798529 | biostudies-literature
| S-EPMC4032273 | biostudies-literature
| S-EPMC4552956 | biostudies-literature
| S-EPMC3329803 | biostudies-literature
| S-EPMC5409830 | biostudies-literature
| S-EPMC7914713 | biostudies-literature
| S-EPMC3612861 | biostudies-literature
| S-SCDT-10_15252-EMMM_202115631 | biostudies-other
| S-EPMC4789278 | biostudies-literature
| S-EPMC3401603 | biostudies-literature